Results - Announcements
Syngene International Ltd share price ticked higher by 1.74% to Rs 366.0 after the company's net profit witnessed a sharp fall of 457.78% to Rs 32.2 crore, while revenue from operations edged up 13.14% to Rs 832.7 crore in Q3FY26 over Q2FY26.
The market capitalization of Healthcare Research, Analytics & Technology industry group stocks on BSE stood at Rs 42333.77 crore, rising 4.19%. It has softened by 4.40% over last one week and dipped slightly by 5.08% in last one month while the market capitalization of Syngene International Ltd has eased by 7.96% and 11.52% in the same period respectively.
Profit before tax (PBT) of Syngene International Ltd stood at Rs 47.0 crore in Q3 FY26, tanking 44.84% year-on-year, and tumbling by 344.79% quarter-on-quarter. EBITDA came in at Rs 119 crore, nosediving by 35.14% YoY and jumping 82.29% sequentially.
Total expenses posted a minor rise of 5.23% to Rs 797.0 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 203.0 crore, advancing by 13.92% YoY, while employee benefits expense was at Rs 272.7 crore, ticking higher by 0.59% YoY.
For the TTM ended FY26, revenue from operations posted a slight growth of 2.64% to Rs 3738.7 crore, while net profit tanked by 36.17% to Rs 316.7 crore, compared to previous TTM. EBITDA soared by 98930% to Rs 847.8 crore, and PBT collapsed by 37.73% to Rs 410.9 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 915.2 crore in FY26, as against Rs 1167.6 crore in FY25.
Syngene International Ltd nosedived by 45.51% in last one year, underperforming the benchmark BSE Sensex which has declined by 13.18% during the same period.